CANCER FACT SHEETS: LIVER CANCER

Similar documents
CANCER FACT SHEETS: BREAST CANCER

CANCER FACT SHEETS: STOMACH CANCER

CANCER FACT SHEETS: ALL CANCERS EXCLUDING NON-MELANOMA SKIN CANCER

The epidemiology of tuberculosis

3.1 PHASE 2 OF THE GLOBAL PROJECT

Table 1. Measles case classification and incidence by country and area, WHO Western Pacific Region,

511,000 (57% new cases) ~50,000 ~30,000

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2018, WHO Western Pacific Region

2010 global TB trends, goals How DOTS happens at country level - an exercise New strategies to address impediments Local challenges

What can be done against XDR-TB?

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 July 2014, WHO Western Pacific Region

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 August 2014, WHO Western Pacific Region

MAPS ON GLOBAL TOBACCO CONTROL POLICY DATA

Figure 1. Distribution of confirmed measles cases with rash onset 1 30 September 2014, WHO Western Pacific Region

Cotton Trade 02/03 03/04 04/05 05/06 06/07 07/08 08/09 09/10 10/11 11/12 12/13

Epidemiology of Hepatitis B in sub-saharan Africa. 7 February 2018 Yusuke Shimakawa, MD, PhD Institut Pasteur

Legend: No confirmed case With confirmed case No case based data

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 March 2018, WHO Western Pacific Region

Figure 1. Incidence rate of total (confirmed and compatible) measles cases with rash onset 1 31 December 2017, WHO Western Pacific Region

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 31 March 2014

TUBERCULOSIS CONTROL IN THE WHO WESTERN PACIFIC REGION In the WHO Western Pacific Region 2002 Report

Figure 1. Confirmed measles cases, WHO Western Pacific Region, 1 30 January 2014

Measles cases MCV1 coverage MCV2 coverage

Measles and Rubella Global Update SAGE 19 October 2017

Legend: No confirmed case With confirmed case No case based data

C R E A E. Consortium to Respond Effectively to the AIDS-TB Epidemic. An International Research Partnership

Legend: No confirmed case With confirmed case No case based data

Copyright 2011 Joint United Nations Programme on HIV/AIDS (UNAIDS) All rights reserved ISBN

宮村参考人提出資料 資料 2-2

Hepatitis B vaccination worldwide: Lessons learnt and the way forward

East Carolina University Continuing Education Courses for Sustainability Symposium

Figure 1. Distribution of confirmed measles cases with rash onset 1 31 December 2014, WHO Western Pacific Region

Name of the presenter

Legend: No confirmed case With confirmed case No case based data

A Review of the Sutezolid (PNU ) Patent Landscape

Polio: A Global Update. DCVMN-- Seoul, Korea Simona Zipursky, WHO/HQ/POL September

Legend: No confirmed case With confirmed case** No case based data

Volume 10 Cervix Cancer Screening

The Gates Challenge. Bill Gates Commencement Address Harvard University Class of 2007

WHO Rotavirus Vaccine Update Dr. Fatima Serhan WHO/FWC/IVB/EPI

EBOLA SITUATION REPORT

Intercountry meeting of national malaria programme managers from countries of HANMAT and PIAM-Net

Need for Chronic Viral Hepatitis Monitoring System

Methodological issues in the use of anthropometry for evaluation of nutritional status

Cancer Incidence in Five Continents. Volume VIII

HPV vaccine the global perspective

TUBERCULOSIS CONTROL WHO WESTERN PACIFIC REGION

Why still Polio Donato Greco ECDC polio consultant 14 April 2016

Latent tuberculosis infection

Global Rotavirus Surveillance Network

CERVICAL CANCER A GLOBAL PERSPECTIVE

Report by the Convention Secretariat. Purpose of the document

HPV Vaccination Global policy perspectives Vacuna VPH Perspectivas de la política de vacunación mundial

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

Global ProhrammeUpdate?

The WHO Global Project on anti-tb drug resistance surveillance: background, objectives, achievements, challenges, next steps

Drug-resistant Tuberculosis

WORLD HEALTH ORGANIZATION. Control of neurocysticercosis

The Scaling-up of TB/HIV Collaborative Activities in the Asia-Pacific

GLOBAL HIV STATISTICS

Fast Facts: Ovarian Cancer

Progress under GAP Pillar 2 "Increase Production Capacity" Contribution of the WHO Technology Transfer Programme. Martin Friede

Prohibition of importation, manufacturing and sale of Smokeless Tobacco products.

Key Issue #1: Why Does Development Vary Among Countries? (299)

TB epidemic and progress towards the Millennium Development Goals

GLOBAL STATISTICS FACT SHEET 2015

Influenza Update N 176

Asthma Disparities: A Global View

Vaccine Preventable Disease Surveillance: Overview. Thomas Cherian, WHO

Influenza Update N 162

Regional workshop on updating national strategic plans for the prevention of re-establishment of local malaria transmission in malaria-free countries

Esophageal cancer Study: China Story

Influenza Update N 159

Oncology in Emerging Markets

IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. VOLUME 93 Carbon Black, Titanium Dioxide, and Talc

Access to treatment and disease burden

Liver Cancer: Epidemiology and Health Disparities. Andrea Goldstein NP, MS, MPH Scientific Director Onyx Pharmaceuticals

XDR-TB Extensively Drug-Resistant Tuberculosis. What, Where, How and Action Steps

Drug resistance TB in People Living with HIV: research questions and priorities.

Module 1: HIV epidemiology, transmission and prevention

DECLARATION ON ACCELERATION OF HIV PREVENTION EFFORTS IN THE AFRICAN REGION

Maternal and Neonatal Tetanus Elimination by Yes, We Can! Global Immunization Meeting 18 th February 2009

DEVELOPMENT. The European Union confronts HIV/AIDS, malaria and tuberculosis. A comprehensive strategy for the new millennium EUROPEAN COMMISSION

Cancer Incidence and Mortality in the Kingdom of Bahrain Statistics and Trends

The Child Dental Health Survey, New South Wales J. Armfield K. Roberts-Thomson J. Spencer AUSTRALIAN RESEARCH CENTRE FOR POPULATION ORAL HEALTH

Cervical Cancer Research in South Africa

Analysis of Mortality Rates of the 5 Most Frequent Primary Cancer Sites in Brazil between 1979 and 2015 for Both Sexes

TB Intensive Minneapolis, Minnesota September 23-26, 2008

WHO Emergency Risk Communication

WHO REGIONAL OFFICE FOR EUROPE RECOMMENDATIONS ON INFLUENZA

IJC International Journal of Cancer

A Summary of Childhood Cancer Statistics in Australia,

WHO Library Cataloguing-in-Publication Data. World health statistics 2011.

RECOMMENDATIONS ON INFLUENZA VACCINATION DURING THE WINTER SEASON

How Is TB Transmitted? Sébastien Gagneux, PhD 20 th March, 2008

2009 Report. Tuberculosis Control. in the Western Pacific Region

The Burden of Heart Failure in the Asia Pacific. Eugenio B. Reyes, M.D. Associate Professor, University of the Philippines, College of Medicine

WHO REPORT ON THE GLOBAL TOBACCO EPIDEMIC,

THE BASICS. WHAT IS THE RED RIBBON? The Red Ribbon is the international symbol of HIV and AIDS awareness. It stands for:

Influenza Weekly Surveillance Bulletin

Transcription:

CANCER FACT SHEETS: LIVER CANCER Estimated age-standardised rates (World) in the world (per 100 000) At a glance China WHO Western Pacific Region Less developed regions World WHO African Region United States of America WHO Eastern Mediterranean Region More developed regions IARC Member State (24 countries) European Union (EU-28) Males Females Incidence Mortality Liver cancer is the fifth most common cancer in men and the ninth most common cancer in women, and it is largely a problem of the less developed regions. In 2012, worldwide, there are estimated to have been 782 000 new cases, with 83% of these cases occurring in less developed regions (50% in China alone). Of this total number of incident cases, 554 000 occurred in men (accounting for 7.5% of all incident cancer cases in men) and 228 000 occurred in women (accounting for 3.4% of all incident cancer cases in women). In men, the highest estimated 2012 age-standardized incidence rates (per 100 000 population) are in eastern and south-eastern Asia (with 31.9 and 22.2 cases, respectively). Intermediate rates are estimated in southern Europe (9.5 cases) and North America (9.3 cases), and the lowest estimated rates are in northern Europe (4.6 cases) and south-central Asia (3.7 cases). In women, the incidence is generally much lower, with the highest estimated 2012 rates in eastern Asia and western Africa (10.2 and 8.1 cases, respectively) and the lowest in northern Europe (1.9 cases) and Micronesia (1.6 cases). WHO Region of the Americas WHO South-East Asia Region WHO European Region India 40 20 0 20 40 Liver cancer is the second most common cause of death from cancer worldwide, estimated to have been responsible for nearly 746 000 deaths in 2012 (9.1% of all cancer deaths that year). The prognosis for liver cancer is very poor (with an overall ratio of mortality to incidence of 0.95), so the geographical patterns in incidence and mortality are very similar.

Estimated incidence, mortality and prevalence (5 years) worlwide in 2012 Estimated numbers Males Females Both sexes Cases Deaths 5-year-prev Cases Deaths 5-year-prev Cases Deaths 5-year-prev World 554 369 521 041 15 296 119 228 082 224 492 17 159 060 782 451 745 533 32 455 179 More developed regions 92 018 80 425 8 549 600 42 284 42 652 8 273 689 134 302 123 077 16 823 289 Less developed regions 462 351 440 616 6 746 519 185 798 181 840 8 885 371 648 149 622 456 15 631 890 WHO African Region 24 791 23 758 467 820 14 032 13 403 895 005 38 823 37 161 1 362 825 WHO Region of the Americas 40 288 34 704 3 843 203 22 872 23 180 4 114 742 63 160 57 884 7 957 945 WHO Eastern Mediterranean Region 19 844 18 893 461 190 9 523 9 056 732 587 29 367 27 949 1 193 777 WHO European Region 47 155 44 087 4 791 316 23 421 24 959 4 909 685 70 576 69 046 9 701 001 WHO South-East Asia Region 54 678 52 351 1 237 475 25 284 24 395 2 040 925 79 962 76 746 3 278 400 WHO Western Pacific Region 367 572 347 208 4 492 687 132 934 129 484 4 463 736 500 506 476 692 8 956 423 IARC Member State (24 countries) 120 066 104 105 9 192 817 56 263 54 741 9 401 981 176 329 158 846 18 594 796 United States of America 22 541 16 863 2 402 172 7 908 7 449 2 373 019 30 449 24 312 4 775 191 China 293 318 281 802 2 495 611 101 452 101 401 2 549 427 394 770 383 203 5 045 038 India 17 236 16 755 664 538 10 180 10 008 1 125 960 27 416 26 763 1 790 498 European Union (EU-28) 35 893 31 881 3 692 805 15 892 16 571 3 463 915 51 785 48 452 7 156 720

Estimated age-standardized rates (World) of incidence cases, males, liver cancer, worldwide in 2012 97.8 7.7 12.6 5.6 7.7 4.0 5.6 < 1.2 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC (http://gco.iarc.fr/today) World Health Organization International Agency for Research on Cancer 2016

Estimated age-standardized rates (World) of incidence cases, males, liver cancer, worldwide in 2012 NORDCAN (www.ancr.nu) ECO (eco.iarc.fr) England: www.ons.gov.uk CI5.iarc.fr CI5.iarc.fr Australia : www.aih.gov.au New Zealand : wwww.health.govt.nz USA: seer.cancer.gov

Estimated age-standardized rates (World) of deaths, males, liver cancer, worldwide in 2012 89.3 7.2 12.5 5.5 7.2 4.1 5.5 < 1.1 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC (http://gco.iarc.fr/today) World Health Organization International Agency for Research on Cancer 2016

Estimated age-standardized rates (World) of incidence cases, females, liver cancer, worldwide in 2012 61.1 3.7 6.4 2.6 3.7 1.9 2.6 < 0.00 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC (http://gco.iarc.fr/today) World Health Organization International Agency for Research on Cancer 2016

Estimated age-standardized rates (World) of incidence cases, females, liver cancer, worldwide in 2012 NORDCAN (www.ancr.nu) ECO (eco.iarc.fr) England: www.ons.gov.uk CI5.iarc.fr CI5.iarc.fr Australia : www.aih.gov.au New Zealand : wwww.health.govt.nz USA: seer.cancer.gov

Estimated age-standardized rates (World) of deaths, females, liver cancer, worldwide in 2012 54.1 3.8 6.3 2.6 3.8 1.9 2.6 < 0.00 No data Not applicable All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization / International Agency for Research on Cancer concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate borderlines for which there may not yet be full agreement. Data source: GLOBOCAN 2012 Graph production: IARC (http://gco.iarc.fr/today) World Health Organization International Agency for Research on Cancer 2016